🔎 Trials Near Me

Beranda › Kanker Endometrium › Washington

Uji klinis Kanker Endometrium di Washington

20 studi untuk Kanker Endometrium mencari peserta di lokasi di Washington.

Kota di Washington

Teks studi resmi (Bahasa Inggris)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Swedish Cancer Institute-Edmonds, Edmonds
  • Swedish Cancer Institute-Issaquah, Issaquah
  • Providence Regional Cancer System-Lacey, Lacey
  • dan 4 lainnya
Menerima pesertaFase 2
Semua usia · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Washington, Fred Hutchinson Cancer Center, Seattle
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • Swedish Cancer Institute-Edmonds, Edmonds
  • Swedish Cancer Institute-Issaquah, Issaquah
  • Swedish Medical Center-First Hill, Seattle
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 2 Okt 2026 · NCT07198074

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • Swedish Cancer Institute-Edmonds, Edmonds
  • Swedish Cancer Institute-Issaquah, Issaquah
  • Swedish Medical Center-First Hill, Seattle
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 28 Sep 2026 · NCT05112601

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

  • Seattle Cancer Care Alliance at South Lake Union - G3630, Seattle
Menerima pesertaFase 1/2
Usia 18 ke atas · Wanita · Diperbarui 24 Sep 2026 · NCT04590326

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  • Swedish Medical Center First Hill, Seattle
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 24 Sep 2026 · NCT05640999

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • University of Washington Fred Hutchinson, Seattle
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05983432

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  • USOR - NW Cancer Specs P.C., Vancouver
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 9 Sep 2026 · NCT07166094

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

  • Swedish Cancer Center, Seattle
  • Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 21 Agu 2026 · NCT05548296

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  • Swedish Cancer Institute, Seattle
  • Fred Hutchinson Cancer Center, Seattle
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT04104776

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

  • Fred Hutchinson Cancer Center, Seattle
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07444814

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Wenatchee Valley Hospital and Clinics, Wenatchee
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT06330064

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • Swedish Cancer Institute, Seattle
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT05579366

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Kennewick
  • Research Site, Seattle
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 29 Jul 2026 · NCT07044336

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

  • Fred Hutchinson Cancer Center, Seattle
  • Summit Cancer Centers, Spokane
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT05377996

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • Fred Hutchinson Cancer Center, Seattle
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT06993844

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  • Medical Oncology Associates, Spokane
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Jun 2026 · NCT07503808

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

  • Fred Hutchinson Cancer Center, Seattle
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06395519

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

  • Swedish Cancer Institute, Seattle
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Nov 2025 · NCT05997017

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Seattle
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.